Musaffa Logo

Our certifications

Independent proof that every stock and portfolio meets halal standards.

How we screen every stock
METHODOLOGY

How we screen every stock

Our 5-step halal methodology, in 90 seconds.

MDCX Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: June 12, 2026

Report Source: 2026 1st Quarter Report

Analyst's Ratings for Medicus Pharma Ltd (MDCX)

Based on 9 analysts giving stock ratings to Medicus Pharma Ltd in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
22
Buy
67
Hold
11
Sell
0
Strong Sell
0
Medicus Pharma Ltd

Medicus Pharma Ltd. Stock Analysis MDCX

United States Health Care Nano Cap Report:
Medicus Pharma Ltd. is a biotech life sciences company, which focuses on accelerating the clinical development programs of novel and disruptive therapeutic assets. The company is headquartered in Conshohocken, Pennsylvania and currently employs 16 full-time employees. The company went IPO on 2023-10-11. SkinJect Inc., a wholly owned subsidiary of the Company, is a development stage, life sciences company focused on commercializing novel, non-invasive treatment for basal cell skin cancer using a patented dissolvable microneedle patch to deliver a chemotherapeutic agent to eradicate tumors cells. The company is conducting a randomized, controlled, double-blind, multicenter clinical study (SKNJCT-003) in the United States and Europe. The company has also commenced a randomized, controlled, double-blind, multicenter clinical study (SKNJCT-004) in the UAE. Its subsidiary, Antev Limited, is a late clinical stage biotech company, developing Teverelix, a GnRH antagonist, as a first in market product for cardiovascular high-risk advanced prostate cancer patients and patients with first acute urinary retention relapse episodes due to enlarged prostate.
Read More

Medicus Pharma Ltd (MDCX) Chart

Key Statistics of Medicus Pharma Ltd (MDCX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.43$0.46

Today's Open

$0.46

Volume

1.39M

P/E Ratio (TTM)

-

52 Week Range

$0.25$3.69

Market Cap

16.20M

Avg. Volume

2.72M

Dividend Yield

-

Financial Metrics & Statements of Medicus Pharma Ltd (MDCX)

FAQ's for Medicus Pharma Ltd (MDCX)

  • According to Musaffa’s Shariah screening methodology, Medicus Pharma Ltd (MDCX) is currently classified as NOT HALAL as of June 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
  • A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Medicus Pharma Ltd using these criteria to determine its compliance status.
  • Muslim investors may consider investing in Medicus Pharma Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
  • Musaffa determines the Shariah status of Medicus Pharma Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
  • The Shariah compliance status of Medicus Pharma Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
  • Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
  • You can check the latest Shariah compliance status of Medicus Pharma Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.